Subscribe to Email Alerts
INOVIQ
  • About Us
    • About INOVIQ
    • Market Opportunity
    • Board
    • The Team
    • Advisors
    • Partners
    • Distributors
    • Compliance
    • Careers
  • Technology
    • Our Science
    • NETs Biomarker Capture Platform
    • SubB2M Pan-Cancer Probe
    • BARD1 Biomarker Technology
    • hTERT ICC Assay
    • Intellectual Property
    • Publications
    • Business Development
  • Products
    • Our Products
    • hTERT ICC Test
    • EXO-NET® Pan-Exosome
      • Product Technology & Features
      • Workflow and Performance
      • Product Ordering
      • Resources
  • Pipeline
    • Development Pipeline
  • Investors
    • Investor Overview
    • ASX Announcements
    • Annual & Financial Reports
    • Presentations
    • Share Price Information
    • AGM
    • INOVIQ Fact Sheet
    • Corporate Governance
    • Shareholder Services
    • FAQ
    • Analyst Reports
    • Conferences & Events
  • Media
    • INOVIQ in the News
  • Contact
    • Contact Us
    • Subscribe to Email Alerts

Resources

Heading &

Sub-heading can be edited through HQI

Products > EXO-NET® Pan-Exosome > Resources
  • Our Products
  • hTERT ICC Test
  • EXO-NET® Pan-Exosome
    • Product Technology & Features
    • Workflow and Performance
    • Product Ordering
    • Resources

Resources


 
9-Mar-2023    Exo -net® Terms And Conditions Of Sale  
 
8-Mar-2023    Instructions for Use -EXO-NET® Pan-Exosome 0.25 ml  
 
8-Mar-2023    Western Blot Analysis of EXO-NET® captured Extracellular Vesicles Application Note  
 
20-Jan-2023    Instructions for Use -EXO-NET® Pan-Exosome 0.5 ml  
 
20-Jan-2023    Instructions for Use -EXO-NET® Pan-Exosome 1 ml  
 

Quick Links

Contact Us

Melbourne:
T: +61 3 9548 7586
23 Normanby Road
Notting Hill VIC 3168
Australia

US Office:
1400 Van Buren St NE
Ste 175 Minneapolis
MN 55413

Online:
E: [email protected]
W: www.inoviq.com

Email Alerts

Subscribe to Email Alerts

Follow Us

Copyright © INOVIQ
Site Map Privacy Search
Site by